About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

GAO-07-882R 1 (2007-06-25)

handle is hein.gao/gaocrptavlo0001 and id is 1 raw text is: 


Sai


        Accountability * Integrity * Reliability
United States Government Accountability Office
Washington, DC 20548


          June 25, 2007

          The Honorable Joe Barton
          Ranking Member
          Committee on Energy and Commerce
          House of Representatives

          Subject: Food and Drug Administration: Methodologies for Identifying and Allocating
                 Costs of Reviewing Medical Device Applications Are Consistent with Federal Cost
                 Accounting Standards, and Staffing Levels for Reviews Have Generally Increased
                 in Recent Years

          Dear Mr. Barton:

          The Food and Drug Administration (FDA) is the agency responsible for ensuring the safety
          and effectiveness of medical devices-such as catheters and artificial hearts-marketed in
          the United States. As part of its regulatory responsibilities, FDA reviews applications
          submitted by medical device companies for devices they wish to market, including devices
          that are new or those that include modifications to already approved devices. The Medical
          Device User Fee and Modernization Act of 2002 (MDUFMA)' authorized FDA, beginning in
          fiscal year 2003, to charge user fees for various types of device applications. User fees were
          intended to provide resources to FDA, to increase staffing for medical device reviews and
          speed the timeliness of reviews, in addition to resources otherwise provided through the
          annual appropriations process.

          Under MDUFMA, FDA is required to report to the congressional committees of jurisdiction
          annually on the implementation of the user fee program. FDA submitted financial reports that
          include information such as amounts collected from user fees, the costs of reviewing device
          applications, and staffing levels FDA dedicated to the review of medical device applications
          for each fiscal year from 2003 through 2005.2 In response to industry concerns about the need
          for more cost information, FDA supplemented these MDUFMA financial reports by reporting






          'Pub. L. No. 107-250, 116 Stat. 1588.

          2Department of Health and Human Services, Food and Drug Administration, FY 2003 MDUFMA
          Financial Report: Required by the Medical Device User Fee and Modernization Act of 2002
          (Washington, D.C., March 2004); FY2004 MDUFMA Financial Report: Required by the Medical
          Device User Fee and Modernization Act of 2002 (Washington, D.C., March 2005); FY 2005 MDUFMA
          Financial Report: Required by the Medical Device User Fee and Modernization Act of 2002
          (Washington, D.C., July 2006).


GAO-07-882R Medical Device Review

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Contact us for annual subscription options:

Already a HeinOnline Subscriber?

profiles profiles most